APO RESEARCH · REPORT
Prostaglandin
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Product & engineering
Understand the product.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Selected research
Market Structure
Global Prostaglandin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Europe is the largest consumption place, with a consumption market share nearly 35% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of about 27%.
CEPIA, Johnson Matthey and Pfizer are the main manufacturers of prostaglandin, they take about 65% of the whole market.
Read the full market overview
This report provides an overview of the global Prostaglandin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Prostaglandin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Prostaglandin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prostaglandin market size, projected growth trends, production technologies, key applications, and end-use industries.
Prostaglandin Segment by Company
Sanofi CEPiA
Kyowa Hakko Pharma
Cayman Chemical
Yonsung Fine Chemicals
Johnson Matthey
Chirogate
Everlight Chemical
ANVI Pharma
AUSUN Pharmaceutical
Aspen Biopharma Labs
Prostaglandin Segment by Type
Human Prostaglandin
Veterinary Prostaglandin
Prostaglandin Segment by Application
Cardiovascular
Gynecological and Obstetrical
Ophthalmologic
Other
Prostaglandin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Prostaglandin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostaglandin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Prostaglandin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Human Prostaglandin
- Veterinary Prostaglandin
Applications
- Cardiovascular
- Gynecological and Obstetrical
- Ophthalmologic
- Other
Companies covered
- Sanofi CEPiA
- Kyowa Hakko Pharma
- Cayman Chemical
- Yonsung Fine Chemicals
- Johnson Matthey
- Chirogate
- Everlight Chemical
- ANVI Pharma
- AUSUN Pharmaceutical
- Aspen Biopharma Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Prostaglandin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Prostaglandin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Prostaglandin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Prostaglandin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Prostaglandin Market Dynamics
- 2.1 Prostaglandin Industry Trends
- 2.2 Prostaglandin Industry Drivers
- 2.3 Prostaglandin Industry Opportunities and Challenges
- 2.4 Prostaglandin Industry Restraints
3 Prostaglandin Market by Manufacturers
- 3.1 Global Prostaglandin Revenue by Manufacturers (2021-2026)
- 3.2 Global Prostaglandin Sales by Manufacturers (2021-2026)
- 3.3 Global Prostaglandin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Prostaglandin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Prostaglandin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Prostaglandin Manufacturers, Product Type & Application
- 3.7 Global Prostaglandin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Prostaglandin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Prostaglandin Players Market Share by Revenue in 2025
- 3.8.3 2025 Prostaglandin Tier 1, Tier 2, and Tier 3
4 Prostaglandin Market by Type
- 4.1 Prostaglandin Type Introduction
- 4.1.1 Human Prostaglandin
- 4.1.2 Veterinary Prostaglandin
- 4.2 Global Prostaglandin Sales by Type
- 4.2.1 Global Prostaglandin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Prostaglandin Sales by Type (2021-2032)
- 4.2.3 Global Prostaglandin Sales Market Share by Type (2021-2032)
- 4.3 Global Prostaglandin Revenue by Type
- 4.3.1 Global Prostaglandin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Prostaglandin Revenue by Type (2021-2032)
- 4.3.3 Global Prostaglandin Revenue Market Share by Type (2021-2032)
5 Prostaglandin Market by Application
- 5.1 Prostaglandin Application Introduction
- 5.1.1 Cardiovascular
- 5.1.2 Gynecological and Obstetrical
- 5.1.3 Ophthalmologic
- 5.1.4 Other
- 5.2 Global Prostaglandin Sales by Application
- 5.2.1 Global Prostaglandin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Prostaglandin Sales by Application (2021-2032)
- 5.2.3 Global Prostaglandin Sales Market Share by Application (2021-2032)
- 5.3 Global Prostaglandin Revenue by Application
- 5.3.1 Global Prostaglandin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Prostaglandin Revenue by Application (2021-2032)
- 5.3.3 Global Prostaglandin Revenue Market Share by Application (2021-2032)
6 Global Prostaglandin Sales by Region
- 6.1 Global Prostaglandin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Prostaglandin Sales by Region (2021-2032)
- 6.2.1 Global Prostaglandin Sales by Region (2021-2026)
- 6.2.2 Global Prostaglandin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Prostaglandin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Prostaglandin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Prostaglandin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Prostaglandin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Prostaglandin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Prostaglandin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Prostaglandin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Prostaglandin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Prostaglandin Revenue by Region
- 7.1 Global Prostaglandin Revenue by Region
- 7.1.1 Global Prostaglandin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Prostaglandin Revenue by Region (2021-2026)
- 7.1.3 Global Prostaglandin Revenue by Region (2027-2032)
- 7.1.4 Global Prostaglandin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Prostaglandin Revenue (2021-2032)
- 7.2.2 North America Prostaglandin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Prostaglandin Revenue (2021-2032)
- 7.3.2 Europe Prostaglandin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Prostaglandin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Prostaglandin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Prostaglandin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Prostaglandin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi CEPiA
- 8.1.1 Sanofi CEPiA Company Information
- 8.1.2 Sanofi CEPiA Business Overview
- 8.1.3 Sanofi CEPiA Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi CEPiA Prostaglandin Product Portfolio
- 8.1.5 Sanofi CEPiA Recent Developments
- 8.2 Kyowa Hakko Pharma
- 8.2.1 Kyowa Hakko Pharma Company Information
- 8.2.2 Kyowa Hakko Pharma Business Overview
- 8.2.3 Kyowa Hakko Pharma Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Kyowa Hakko Pharma Prostaglandin Product Portfolio
- 8.2.5 Kyowa Hakko Pharma Recent Developments
- 8.3 Cayman Chemical
- 8.3.1 Cayman Chemical Company Information
- 8.3.2 Cayman Chemical Business Overview
- 8.3.3 Cayman Chemical Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Cayman Chemical Prostaglandin Product Portfolio
- 8.3.5 Cayman Chemical Recent Developments
- 8.4 Yonsung Fine Chemicals
- 8.4.1 Yonsung Fine Chemicals Company Information
- 8.4.2 Yonsung Fine Chemicals Business Overview
- 8.4.3 Yonsung Fine Chemicals Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Yonsung Fine Chemicals Prostaglandin Product Portfolio
- 8.4.5 Yonsung Fine Chemicals Recent Developments
- 8.5 Johnson Matthey
- 8.5.1 Johnson Matthey Company Information
- 8.5.2 Johnson Matthey Business Overview
- 8.5.3 Johnson Matthey Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Johnson Matthey Prostaglandin Product Portfolio
- 8.5.5 Johnson Matthey Recent Developments
- 8.6 Chirogate
- 8.6.1 Chirogate Company Information
- 8.6.2 Chirogate Business Overview
- 8.6.3 Chirogate Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Chirogate Prostaglandin Product Portfolio
- 8.6.5 Chirogate Recent Developments
- 8.7 Everlight Chemical
- 8.7.1 Everlight Chemical Company Information
- 8.7.2 Everlight Chemical Business Overview
- 8.7.3 Everlight Chemical Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Everlight Chemical Prostaglandin Product Portfolio
- 8.7.5 Everlight Chemical Recent Developments
- 8.8 ANVI Pharma
- 8.8.1 ANVI Pharma Company Information
- 8.8.2 ANVI Pharma Business Overview
- 8.8.3 ANVI Pharma Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ANVI Pharma Prostaglandin Product Portfolio
- 8.8.5 ANVI Pharma Recent Developments
- 8.9 AUSUN Pharmaceutical
- 8.9.1 AUSUN Pharmaceutical Company Information
- 8.9.2 AUSUN Pharmaceutical Business Overview
- 8.9.3 AUSUN Pharmaceutical Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 AUSUN Pharmaceutical Prostaglandin Product Portfolio
- 8.9.5 AUSUN Pharmaceutical Recent Developments
- 8.10 Aspen Biopharma Labs
- 8.10.1 Aspen Biopharma Labs Company Information
- 8.10.2 Aspen Biopharma Labs Business Overview
- 8.10.3 Aspen Biopharma Labs Prostaglandin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Aspen Biopharma Labs Prostaglandin Product Portfolio
- 8.10.5 Aspen Biopharma Labs Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Prostaglandin Value Chain Analysis
- 9.1.1 Prostaglandin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Prostaglandin Production Mode & Process
- 9.2 Prostaglandin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Prostaglandin Distributors
- 9.2.3 Prostaglandin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst